Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19922 | 484 | 27.9 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
608 | 3 | CIRCULATING TUMOR CELLS//CEA//CYFRA 21 1 | 14209 |
1581 | 2 | CYFRA 21 1//CEA//CARCINOEMBRYONIC ANTIGEN | 7240 |
19922 | 1 | SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3 | 484 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SQUAMOUS CELL CARCINOMA ANTIGEN | authKW | 2336009 | 15% | 51% | 72 |
2 | SCC ANTIGEN | authKW | 576796 | 3% | 57% | 16 |
3 | SERPINB3 | authKW | 425843 | 2% | 75% | 9 |
4 | SCC AG | authKW | 394874 | 3% | 48% | 13 |
5 | SQUAMOUS CELL CARCINOMA ANTIGEN 1 | authKW | 365006 | 2% | 64% | 9 |
6 | SCCA IGM | authKW | 315443 | 1% | 100% | 5 |
7 | SQUAMOUS CELL CARCINOMA ANTIGEN 2 | authKW | 315443 | 1% | 100% | 5 |
8 | SCCA2 | authKW | 262867 | 1% | 83% | 5 |
9 | SCCA1 | authKW | 252350 | 1% | 67% | 6 |
10 | SQUAMOUS CELL CARCINOMA ANTIGEN SCCA | authKW | 201882 | 1% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 4814 | 51% | 0% | 249 |
2 | Obstetrics & Gynecology | 2166 | 21% | 0% | 100 |
3 | Medical Laboratory Technology | 165 | 3% | 0% | 16 |
4 | Pathology | 135 | 5% | 0% | 26 |
5 | Medicine, Research & Experimental | 50 | 5% | 0% | 24 |
6 | Otorhinolaryngology | 38 | 2% | 0% | 11 |
7 | Cell Biology | 34 | 6% | 0% | 31 |
8 | Dermatology | 32 | 2% | 0% | 12 |
9 | Gastroenterology & Hepatology | 14 | 2% | 0% | 12 |
10 | Biochemical Research Methods | 9 | 2% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERUNIV LIVER PATHOPHYSIOL | 81110 | 1% | 43% | 3 |
2 | CANC RELATED SYMPTOMS NICRS | 63089 | 0% | 100% | 1 |
3 | CNR RIC FISIOPATOL SHOCK | 63089 | 0% | 100% | 1 |
4 | FONDAZ ELEONORA LORILLARD SPENCER CENCI | 63089 | 0% | 100% | 1 |
5 | GEN INTRO SURG | 63089 | 0% | 100% | 1 |
6 | GEN REG HOSPABO FDN | 63089 | 0% | 100% | 1 |
7 | GRP HOSP BICETRE PAUL BROUSSE | 63089 | 0% | 100% | 1 |
8 | HERITABLE DIS BRANCH | 63089 | 0% | 100% | 1 |
9 | HP PATHOLU785 | 63089 | 0% | 100% | 1 |
10 | HUNAN PROV GERONTOL | 63089 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR BIOLOGY | 8616 | 6% | 0% | 29 |
2 | GYNECOLOGIC ONCOLOGY | 8424 | 8% | 0% | 39 |
3 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2761 | 3% | 0% | 14 |
4 | CANCER | 1183 | 5% | 0% | 23 |
5 | INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 1116 | 1% | 0% | 4 |
6 | CANCER DETECTION AND PREVENTION | 988 | 1% | 0% | 5 |
7 | JOURNAL OF GYNECOLOGIC ONCOLOGY | 725 | 0% | 1% | 2 |
8 | ANTICANCER RESEARCH | 721 | 3% | 0% | 15 |
9 | ACTA HISTOCHEMICA ET CYTOCHEMICA | 553 | 1% | 0% | 4 |
10 | EKSPERIMENTALNAYA ONKOLOGIYA | 453 | 1% | 0% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SQUAMOUS CELL CARCINOMA ANTIGEN | 2336009 | 15% | 51% | 72 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN |
2 | SCC ANTIGEN | 576796 | 3% | 57% | 16 | Search SCC+ANTIGEN | Search SCC+ANTIGEN |
3 | SERPINB3 | 425843 | 2% | 75% | 9 | Search SERPINB3 | Search SERPINB3 |
4 | SCC AG | 394874 | 3% | 48% | 13 | Search SCC+AG | Search SCC+AG |
5 | SQUAMOUS CELL CARCINOMA ANTIGEN 1 | 365006 | 2% | 64% | 9 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+1 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+1 |
6 | SCCA IGM | 315443 | 1% | 100% | 5 | Search SCCA+IGM | Search SCCA+IGM |
7 | SQUAMOUS CELL CARCINOMA ANTIGEN 2 | 315443 | 1% | 100% | 5 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+2 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+2 |
8 | SCCA2 | 262867 | 1% | 83% | 5 | Search SCCA2 | Search SCCA2 |
9 | SCCA1 | 252350 | 1% | 67% | 6 | Search SCCA1 | Search SCCA1 |
10 | SQUAMOUS CELL CARCINOMA ANTIGEN SCCA | 201882 | 1% | 80% | 4 | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+SCCA | Search SQUAMOUS+CELL+CARCINOMA+ANTIGEN+SCCA |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GADDUCCI, A , TANA, R , FANUCCHI, A , GENAZZANI, AR , (2007) BIOCHEMICAL PROGNOSTIC FACTORS AND RISK OF RELAPSES IN PATIENTS WITH CERVICAL CANCER.GYNECOLOGIC ONCOLOGY. VOL. 107. ISSUE 1. P. S23-S26 | 45 | 85% | 15 |
2 | GADDUCCI, A , TANA, R , COSIO, S , GENAZZANI, AR , (2008) THE SERUM ASSAY OF TUMOUR MARKERS IN THE PROGNOSTIC EVALUATION, TREATMENT MONITORING AND FOLLOW-UP OF PATIENTS WITH CERVICAL CANCER: A REVIEW OF THE LITERATURE.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 66. ISSUE 1. P. 10-20 | 55 | 55% | 55 |
3 | BIASIOLO, A , TONO, N , RUVOLETTO, M , QUARTA, S , TURATO, C , VILLANO, G , BENEDUCE, L , FASSINA, G , MERKEL, C , GATTA, A , ET AL (2012) IGM-LINKED SERPINB3 AND SERPINB4 IN SERA OF PATIENTS WITH CHRONIC LIVER DISEASE.PLOS ONE. VOL. 7. ISSUE 7. P. - | 34 | 83% | 4 |
4 | DE BRUIJN, HWA , DUK, JM , VAN DER ZEE, AGJ , PRAS, E , WILLEMSE, PHB , BOONSTRA, H , HOLLEMA, H , MOURITS, MJE , DE VRIES, EGE , AALDERS, JG , (1998) THE CLINICAL VALUE OF SQUAMOUS CELL CARCINOMA ANTIGEN IN CANCER OF THE UTERINE CERVIX.TUMOR BIOLOGY. VOL. 19. ISSUE 6. P. 505-516 | 46 | 82% | 33 |
5 | YOON, SM , SHIN, KH , KIM, JY , SEO, SS , PARK, SY , KANG, S , CHO, KH , (2007) THE CLINICAL VALUES OF SQUAMOUS CELL CARCINOMA ANTIGEN AND CARCINOEMBRYONIC ANTIGEN IN PATIENTS WITH CERVICAL CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY.INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. VOL. 17. ISSUE 4. P. 872 -878 | 28 | 97% | 16 |
6 | PRAS, E , WILLEMSE, PHB , CANRINUS, AA , DE BRUIJN, HWA , SLUITER, WJ , TEN HOOR, KA , AALDERS, JG , SZABO, BG , DE VRIES, EGE , (2002) SERUM SQUAMOUS CELL CARCINOMA ANTIGEN AND CYFRA 21-1 IN CERVICAL CANCER TREATMENT.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. VOL. 52. ISSUE 1. P. 23-32 | 36 | 82% | 38 |
7 | CHECHLINSKA, M , KOWALEWSKA, M , BRZOSKA-WOJTOWICZ, E , RADZISZEWSKI, J , PTASZYNSKI, K , RYS, J , KAMINSKA, J , NOWAK, R , (2010) SQUAMOUS CELL CARCINOMA ANTIGEN 1 AND 2 EXPRESSION IN CULTURED NORMAL PERIPHERAL BLOOD MONONUCLEAR CELLS AND IN VULVAR SQUAMOUS CELL CARCINOMA.TUMOR BIOLOGY. VOL. 31. ISSUE 6. P. 559-567 | 28 | 88% | 6 |
8 | PIAO, X , KONG, TW , CHANG, SJ , PAEK, J , CHUN, M , RYU, HS , (2015) PRETREATMENT SERUM CYFRA 21-1 LEVEL CORRELATES SIGNIFICANTLY WITH SURVIVAL OF CERVICAL CANCER PATIENTS: A MULTIVARIATE ANALYSIS OF 506 CASES.GYNECOLOGIC ONCOLOGY. VOL. 138. ISSUE 1. P. 89 -93 | 22 | 81% | 1 |
9 | NUSTAD, K , DOWELL, BL , DAVIS, GJ , STEWART, K , NILSSON, O , ROIJER, E , SUMINAMI, Y , NAWATA, S , CATALTEPE, S , SILVERMAN, GA , ET AL (2004) CHARACTERIZATION OF MONOCLONAL ANTIBODIES DIRECTED AGAINST SQUAMOUS CELL CARCINOMA ANTIGENS: REPORT OF THE TD-10 WORKSHOP.TUMOR BIOLOGY. VOL. 25. ISSUE 1-2. P. 69-90 | 26 | 87% | 10 |
10 | SALVATICI, M , ACHILARRE, MT , SANDRI, MT , BOVERI, S , VANNA, Z , LANDONI, F , (2016) SQUAMOUS CELL CARCINOMA ANTIGEN (SCC-AG) DURING FOLLOW-UP OF CERVICAL CANCER PATIENTS: ROLE IN THE EARLY DIAGNOSIS OF RECURRENCE.GYNECOLOGIC ONCOLOGY. VOL. 142. ISSUE 1. P. 115 -119 | 22 | 71% | 1 |
Classes with closest relation at Level 1 |